Seattle startup Receptor Life Sciences has raised $9.7 million to move its CBD-based therapeutic candidate for acute anxiety through clinical… Read More
Secretive biotechnology company Receptor Life Sciences has raised a funding round totaling just over $7.5 million, according to a filing with… Read More
